Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06564571 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Artificial Intelligence in Endoscopic Ultrasound

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 1500 to 310
    • Study title revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.
Trial Details
NCT Number NCT06564571
Lead Sponsor Orlando Health, Inc.
Conditions
(from sponsor)		 Pancreatic Cancer, Pancreas Disease, Pancreatic Cyst
Related terms Pancreatic Cyst, Pancreatic Diseases, Pancreatic Neoplasms
Enrollment 310 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov